Hims Hers Health Inc (HIMS)

Currency in USD
19.33
-3.69(-16.03%)
Closed·
19.20-0.13(-0.67%)
·
Unusual trading volume
Trading near 52-week Low
Earnings results expected in 0 days
HIMS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.3519.52
52 wk Range
16.3572.98
Key Statistics
Prev. Close
23.02
Open
17.83
Day's Range
16.35-19.52
52 wk Range
16.35-72.98
Volume
143.27M
Average Volume (3m)
20.27M
1-Year Change
-54.5711%
Book Value / Share
2.57
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HIMS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
38.15
Upside
+97.38%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Hims Hers Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Hims Hers Health Company Profile

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company’s curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. The company also provides Labs which measures key markers over time and provides doctor-developed action plans. Hims & Hers Health, Inc. is based in San Francisco, California.

Hims Hers Health Inc Earnings Call Summary for Q3/2025

  • Hims & Hers Health Q3 2025 reported mixed results with EPS of $0.06 (missing $0.10 forecast) while revenue exceeded expectations at $600 million (up 49% YoY), driving a 3.45% aftermarket stock rebound.
  • The company added 30,000 new subscribers sequentially (20% YoY growth) and achieved $78 million in adjusted EBITDA (50% YoY increase) with margins exceeding 13%.
  • Management raised full-year 2025 guidance to $2.335-2.355 billion in revenue (58-59% YoY growth) and $307-317 million in adjusted EBITDA, maintaining a 13% margin.
  • CEO Andrew Dudum outlined ambitious long-term targets of $6.5 billion in revenue and $1.3 billion in adjusted EBITDA by 2030, driven by new product launches and international expansion.
  • New offerings in low testosterone and menopause treatments highlight the company's strategic focus on becoming 'the largest global consumer health platform.'
Last Updated: 03/11/2025, 23:28
Read Full Transcript

Compare HIMS to Peers and Sector

Metrics to compare
HIMS
Peers
Sector
Relationship
P/E Ratio
39.2x9.5x−0.5x
PEG Ratio
1.520.040.00
Price/Book
9.0x0.9x2.6x
Price / LTM Sales
2.4x0.8x3.3x
Upside (Analyst Target)
78.5%59.0%45.6%
Fair Value Upside
Unlock32.5%5.8%Unlock

Analyst Ratings

3 Buy
10 Hold
2 Sell
Ratings:
15 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 38.15
(+97.38% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BofA Securities
Sell13.00-32.75%21.00Maintain09/02/2026
TD Cowen
Hold20.00+3.47%30.00Maintain09/02/2026
Leerink Partners
Hold20.00+3.47%24.00Maintain09/02/2026
Needham
Hold---Maintain09/02/2026
BTIG
Buy60.00+210.40%-Maintain09/02/2026

Earnings

Latest Release
Nov 03, 2025
EPS / Forecast
0.06 / 0.10
Revenue / Forecast
600.00M / 580.37M
EPS Revisions
Last 90 days

People Also Watch

46.150
IREN
+10.33%
102.120
ASTS
+0.32%
75.05
OKLO
+5.56%
583.40
SNDK
-2.43%
92.81
NBIS
+7.79%

FAQ

What Is the Hims Hers Health (HIMS) Share Price Today?

The live Hims Hers Health share price today is 19.33

What Stock Exchange Does Hims Hers Health (HIMS) Trade On?

Hims Hers Health is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Hims Hers Health?

The stock symbol (also called a 'ticker') for Hims Hers Health is "HIMS."

What Is the Current Hims Hers Health Market Cap?

As of today, Hims Hers Health market capitalisation is 4.38B.

What Is Hims Hers Health's (HIMS) Earnings Per Share (TTM)?

The Hims Hers Health EPS is currently 0.54 (Trailing Twelve Months).

When Is the Next Hims Hers Health Earnings Date?

Hims Hers Health's next earnings report will be released on 23 Feb 2026.

Is HIMS a Buy or Sell From a Technical Analyst Perspective?

Based on today's Hims Hers Health moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Hims Hers Health Stock Split?

Hims Hers Health has split 0 times. (See the HIMS stock split history page for full effective split date and price information.)

How Many Employees Does Hims Hers Health Have?

Hims Hers Health has 1637 employees.

What is the current trading status of Hims Hers Health (HIMS)?

As of 09 Feb 2026, Hims Hers Health (HIMS) is trading at a price of 19.33, with a previous close of 23.02. The stock has fluctuated within a day range of 16.35 to 19.52, while its 52-week range spans from 16.35 to 72.98.

What Is Hims Hers Health (HIMS) Price Target According to Analysts?

The average 12-month price target for Hims Hers Health is USD38.15, with a high estimate of USD68 and a low estimate of USD24. 3 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +97.38% Upside potential.

What Is the HIMS Premarket Price?

HIMS's last pre-market stock price is 17.83. The pre-market share volume is 10,140,000.00, and the stock has decreased by -5.19, or -22.55%.

What Is the HIMS After Hours Price?

HIMS's last after hours stock price is 19.20, the stock has decreased by -0.13, or -0.67%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.